Skip to menu Skip to content Skip to footer
Dr Andrea Henden
Dr

Andrea Henden

Email: 

Overview

Availability

Dr Andrea Henden is:
Available for supervision

Works

Search Professor Andrea Henden’s works on UQ eSpace

52 works between 2009 and 2025

1 - 20 of 52 works

2025

Journal Article

The gut microbiome in B cell lymphoma

Vickers, Darcy, Martynchyk, Arina, Henden, Andrea, Smibert, Olivia C., Hawkes, Eliza A. and Chong, Geoff (2025). The gut microbiome in B cell lymphoma. Blood Reviews 101357, 101357. doi: 10.1016/j.blre.2025.101357

The gut microbiome in B cell lymphoma

2025

Journal Article

Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvement

Cashion, Catelyn, Li, Jian, Farina, Sergio, Inam, Shafqat, Jeffrey, Anthony, MacDonald, Ross, Buss, Thomas, Vanguru, Vinay, Boyle, Stephen, Bishop, David, Brown, Christina, Barraclough, Allison, Tam, Constantine, Henden, Andrea, Dickinson, Michael, Blyth, Emily and Dowling, Mark (2025). Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvement. Blood, 146 (Supplement 1), 1936-1936. doi: 10.1182/blood-2025-1936

Real-world outcomes with CAR T-cell therapy for secondary central nervous system lymphoma are similar between patients with active versus historical involvement

2025

Conference Publication

Multiomic dissection of immune-privileged DLBCL reveals divergent immune subtypes in testicular and primary central nervous system lymphoma

Burgess, Melinda, Hawula, Zachary, Tuczko, Nella, Kempe, Sarah, Murigneux, Valentine, Swain, Fiona, Chowdhury, Rakin, Bradbury, Lucy, Antczak, Magdalena, Mehdi, Ahmed, Hawkes, Eliza, Wight, Joel, Henden, Andrea, Sheehy, Joshua, Gandhi, Maher, Jiang, Sizun and Keane, Colm (2025). Multiomic dissection of immune-privileged DLBCL reveals divergent immune subtypes in testicular and primary central nervous system lymphoma. 67th ASH Annual Meeting and Exposition, Orlando, FL, United States, 6-9 December 2025. Washington, DC, United States: American Society of Hematology. doi: 10.1182/blood-2025-147

Multiomic dissection of immune-privileged DLBCL reveals divergent immune subtypes in testicular and primary central nervous system lymphoma

2025

Journal Article

Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in Australia

Li, Jian, Dowling, Mark, Jeffrey, Anthony, Farina, Sergio, Boyle, Stephen, MacDonald, Ross, Inam, Shafqat, Ma, Chun Kei Kris, Vanguru, Vinay, Perera, Nilu, Scott, Hamish, Dickinson, Michael, Seymour, John, Henden, Andrea, Blyth, Emily, Ho, Phoebe Joy, Tam, Constantine, Anderson, Mary Ann and Thompson, Philip (2025). Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in Australia. Blood, 146 (Supplement 1), 2779-2779. doi: 10.1182/blood-2025-2779

Multi-centre real-world outcome of patients with Richter transformation receiving CD19-directed commercial CAR T-cell therapy in Australia

2025

Journal Article

A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortium

Dowling, Mark, Vanguru, Vinay, Boyle, Stephen, Cashion, Catelyn, Inam, Shafqat, Buss, Thomas, Jeffrey, Anthony, Scott, Hamish, MacDonald, Ross, Li, Jian, O'Leary, Nicole, Minson, Adrian, Brown, Christina, Anderson, Mary Ann, Sutrave, Gaurav, Belbachir, Safia, Butler, Jason, Curley, Cameron, Barraclough, Allison, Tam, Constantine, Henden, Andrea, Blyth, Emily, Ho, Phoebe Joy, Harrison, Simon and Dickinson, Michael (2025). A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortium. Blood, 146 (Supplement 1), 399-399. doi: 10.1182/blood-2025-399

A simple scoring system for response and toxicity following lymphoma CAR-T: Results from the Australian CAR-T real-world consortium

2025

Journal Article

Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation

Nakagaki, Midori, Hajkowicz, Krispin, Roberts, Jason A and Henden, Andrea S (2025). Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation. Expert Review of Anti-infective Therapy, ahead-of-print (ahead-of-print), 1-14. doi: 10.1080/14787210.2025.2527970

Cause and effect? A review of the impact of antibiotics on the gut microbiome in patients undergoing hematopoietic stem cell transplantation

2025

Journal Article

p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice

Nelles, Ricky, Tallack, Michael R., Tate, Courtney, Hunt, Stewart, Aung, Hnin, Henden, Andrea, Jones, Lee and Seymour, Louise (2025). p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice. Pathology, 57 (4), 489-494. doi: 10.1016/j.pathol.2024.11.011

p53 immunohistochemistry staining is a rapid screening method for TP53 mutation in myeloid malignancies suitable for integration into routine diagnostic laboratory practice

2025

Journal Article

Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies

Lindsay, Daniel, Henden, Andrea, Nelles, Ricky, Elliott, Thomas M. and Collins, Louisa G. (2025). Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies. Applied Health Economics and Health Policy, 23 (3) 659595, 507-517. doi: 10.1007/s40258-024-00927-8

Exploratory cost-utility analysis of a 37-gene panel versus usual care to guide therapy for patients with intermediate-risk myeloid malignancies

2025

Journal Article

Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease

Henden, Andrea S, Lineburg, Katie E, Panikkar, Archana, Mahajan, Arushi, Nelles, Ricky, Wright, Emma, Crooks, Pauline, Raju, Jyothy, Le Texier, Laetitia, Swaminathan, Srividhya, Beagley, Leone, Best, Shannon, Solomon, Matthew, Reddiex, Hilary, Kennedy, Glen, Tey, Siok‐Keen, Neller, Michelle A, Khanna, Rajiv and Smith, Corey (2025). Allogeneic ‘off‐the‐shelf’ SARS‐CoV‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease. Clinical & Translational Immunology, 14 (6) e70038, e70038. doi: 10.1002/cti2.70038

Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ disease

2024

Conference Publication

Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse

Swain, Fiona, Burgess, Melinda, Kempe, Sarah, Sabdia, Muhammed B., Henden, Andrea S., Wight, Joel, Hawkes, Eliza A., Mutsando, Howard, Talaulikar, Dipti, Merida de Long, Lilia, Birch, Simone, Wyche, Penelope, Hawula, Zachary, Chowdhury, Rakin, Gandhi, Maher K. and Keane, Colm (2024). Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-199352

Multiomics Analysis of Paired Diagnosis and Relapse DLBCL Biopsies Shows a Reduction in T Cell Infiltration and Function at Relapse

2024

Conference Publication

Real World Outcomes of Ruxolitinib Treatment of Steroid Refractory/Dependent Acute Graft Versus Host Disease

Leung, Becky, Butler, Jason, Curley, Cameron, Henden, Andrea S., Hunt, Stewart, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Real World Outcomes of Ruxolitinib Treatment of Steroid Refractory/Dependent Acute Graft Versus Host Disease. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-210424

Real World Outcomes of Ruxolitinib Treatment of Steroid Refractory/Dependent Acute Graft Versus Host Disease

2024

Conference Publication

Allogeneic Haematopoietic Stem Cell Transplantation Is Safe and Effective for Myeloid Neoplasms with Germline DDX41 Mutation

Nelles, Ricky, Butler, Jason, Curley, Cameron, Henden, Andrea S., Hunt, Stewart, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Allogeneic Haematopoietic Stem Cell Transplantation Is Safe and Effective for Myeloid Neoplasms with Germline DDX41 Mutation. 66th ASH Annual Meeting, San Diego, CA United States, 7-10 December 2024. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood-2024-209669

Allogeneic Haematopoietic Stem Cell Transplantation Is Safe and Effective for Myeloid Neoplasms with Germline DDX41 Mutation

2024

Journal Article

Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy

Sheehy, Joshua, Scott, Ashleigh P., Henden, Andrea S., Kennedy, Glen, Redmond, Andrew M. and Stewart, Adam G. (2024). Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy. Journal of Antimicrobial Chemotherapy, 79 (8), 2040-2047. doi: 10.1093/jac/dkae209

Low rates of complications and β-lactam resistance in viridans group streptococci bloodstream infection among cancer patients receiving chemotherapy

2024

Journal Article

Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells

Ekwe, Adaeze Precious, Au, Raymond, Zhang, Ping, McEnroe, Benjamin, Tan, Mei Ling, Saldan, Alda, Henden, Andrea S., Hutchins, Cheryl, Henderson, Ashleigh, Mudie, Kari, Kerr, Keri, Fuery, Madonna, Kennedy, Glen A., Hill, Geoffrey R. and Tey, Siok-Keen (2024). Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells. Cytotherapy, 26 (7), 719-728. doi: 10.1016/j.jcyt.2024.02.023

Clinical grade multiparametric cell sorting and gene-marking of regulatory T cells

2024

Journal Article

IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation

Zhang, Ping, Fleming, Peter, Andoniou, Christopher E., Waltner, Olivia G., Bhise, Shruti S., Martins, Jose Paulo, McEnroe, Benjamin A., Voigt, Valentina, Daly, Sheridan, Kuns, Rachel D., Ekwe, Adaeze P., Henden, Andrea S., Saldan, Alda, Olver, Stuart, Varelias, Antiopi, Smith, Corey, Schmidt, Christine R., Ensbey, Kathleen S., Legg, Samuel R.W., Sekiguchi, Tomoko, Minnie, Simone A., Gradwell, Mark, Wagenaar, Irma, Clouston, Andrew D., Koyama, Motoko, Furlan, Scott N., Kennedy, Glen A., Ward, E Sally, Degli-Esposti, Mariapia A. ... Tey, Siok-Keen (2024). IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation. Journal of Clinical Investigation, 134 (7) e174184, 1-15. doi: 10.1172/jci174184

IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation

2024

Journal Article

Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy

Perera, Nilu, Baidya, Shoma, Weber, Nicholas, Mudie, Kari, Butler, Jason, Curley, Cameron, Henden, Andrea, Hunt, Stewart, Subramoniapillai, Elango, Tey, Siok‐Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2024). Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy. Transfusion, 64 (4), 762-765. doi: 10.1111/trf.17793

Granulocyte transfusion supportive care for prolonged cytopenias post CD19 CAR T cell therapy

2023

Journal Article

ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease

Hamad, Nada, Bilmon, Ian, Chee, Lynette, Henden, Andrea, Johnston, Anna, Purtill, Duncan, Bajel, Ashish, Tey, Siok‐Keen, Yeung, David, Cole, Theresa, Lewis, Clinton and Butler, Jason (2023). ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease. Internal Medicine Journal, 53 (12), 2319-2329. doi: 10.1111/imj.16255

ANZTCT consensus position statement on ruxolitinib in steroid‐refractory acute and chronic graft‐versus‐host disease

2023

Conference Publication

Feasibility of prebiotic enteral nutrition provision during allogeneic stem cell transplantation

Andersen, S., Kennedy, G., Banks, M. and Henden, A. (2023). Feasibility of prebiotic enteral nutrition provision during allogeneic stem cell transplantation. 45th ESPEN Congress 2023, Lyon, France, 11-14 September 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.clnesp.2023.09.012

Feasibility of prebiotic enteral nutrition provision during allogeneic stem cell transplantation

2023

Journal Article

Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia

Wong, Philip, Whiteman, David C., Olsen, Catherine M., Yuan, Yin, Butler, Jason, Curley, Cameron, Durrant, Simon, Henden, Andrea, Morton, James, Subramoniapillai, Elango, Stewart, Caroline, Tey, Siok-Keen, Kennedy, Glen A. and Scott, Ashleigh P. (2023). Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia. Bone Marrow Transplantation, 59 (1) s41409-023-02138-6, 144-146. doi: 10.1038/s41409-023-02138-6

Quantifying skin cancer risk following allogeneic haematopoietic cell transplant in Queensland, Australia

2023

Journal Article

Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

Peri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine, 23 (8), 4563-4573. doi: 10.1007/s10238-023-01206-x

Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years

Funding

Current funding

  • 2024 - 2029
    BrainCAR19 Study- Treatment of relapsed Primary Brain Lymphoma with CD19 directed CAR-T cells
    NHMRC MRFF CTA - Clinical Trials Activity
    Open grant

Supervision

Availability

Dr Andrea Henden is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Media

Enquiries

For media enquiries about Dr Andrea Henden's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au